Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2002 Aug;46(8):2723-6.
doi: 10.1128/AAC.46.8.2723-2726.2002.

Hematologic effects of linezolid: summary of clinical experience

Affiliations

Hematologic effects of linezolid: summary of clinical experience

Stanton L Gerson et al. Antimicrob Agents Chemother. 2002 Aug.

Abstract

Linezolid has been associated with reversible myelosuppression. Clinical trial data were evaluated for anemia, thrombocytopenia, and neutropenia. Thrombocytopenia and a slight increased risk for anemia were evident at > or =2 weeks of linezolid treatment. Hematologic abnormalities were consistent with mild, reversible, duration-dependent myelosuppression. Appropriate monitoring is warranted with linezolid use.

PubMed Disclaimer

Figures

FIG. 1.
FIG. 1.
Patients with at least one substantially low PLTC, hemoglobin value, or neutrophil count in linezolid and comparator groups—cumulative percentage over time.

References

    1. Adult AIDS Clinical Trial Group (AACTG). 1992. Table for grading severity of adult adverse experiences. National Institute of Allergy and Infectious Diseases (NIAID), Bethesda, Md.
    1. Alanis, A., and A. J. Weinstein. 1983. Adverse reactions associated with the use of oral penicillins and cephalosporins. Med. Clin. N. Am. 67:113-129. - PubMed
    1. Alexander, D. P., M. E. Russo, D. E. Fohrman, and G. Rothstein. 1983. Nafcillin-induced platelet dysfunction and bleeding. Antimicrob. Agents Chemother. 23:59-62. - PMC - PubMed
    1. Beris, P., and P. A. Miescher. 1988. Hematological complications of antiinfectious agents. Sem. Hematol. 25:123-139. - PubMed
    1. Brickner, S. J., D. K. Hutchinson, M. R. Barbachyn, R. R. Mannienen, D. A. Ulanowicz, K. C. Grega, S. K. Hendes, D. S. Toops, C. W. Ford, and G. E. Zurenko. 1996. Synthesis and antibacterial activity of U-100592 and U-100766, two oxazolidinone antibacterial agents for the potential treatment of multidrug-resistant gram-positive bacterial infections. J. Med. Chem. 39:673-679. - PubMed